Production and standardization of fungal antigens and antiserums for the diagnosis of systematic mycoses

Authors

  • María L. García de López Institute of Chemical and Biological Research
  • Heidi Logemann Institute of Chemical and Biological Research
  • Teresa M. Vásquez Institute of Chemical and Biological Research

DOI:

https://doi.org/10.54495/Rev.Cientifica.v7i1.437

Keywords:

production, standardization, fungal antigens, fungal antiserums, diagnosis, systematic mycoses

Abstract

Guatemala's ecological conditions favor the growth of a wide variety of fungi, including the causative agents of deep-seated mycoses, the most important of which are coccidioidomycosis and histoplasmosis.

The symptoms of the pulmonary process they cause are very similar to those of tuberculosis, so differential diagnosis is based solely on laboratory procedures, which are based on the observation and/or isolation of the causative agent from clinical material. However, in 30% of cases, isolation is not possible, so serological tests are required for confirmation, as these have proven to be sensitive and specific.

The problem with the use of serology is that antigens and antiserums are difficult to obtain in our environment and are expensive.

The Mycology Laboratory, through its services, has diagnosed cases of histoplasmosis, coccidioidomycosis, paracoccidioidomycosis, and others. Therefore, it is necessary to obtain fungal antigens and antiserums using Guatemalan strains and the techniques recommended by the CDC. This will allow, once the tests are standardized, to detect more cases than those diagnosed so far. Furthermore, seroepidemiological studies can be conducted to establish the true status of systemic mycoses in our country.

Infections caused by "opportunistic" fungi, which are low-virulence and some of which are commensals of humans, such as C. albicans, have gained significant importance in recent years, as the incidence of these infections occurs alongside the use of antibiotics, immunosuppressants, and other procedures that diminish the host's immune response. Furthermore, with the emergence of Acquired Immune Deficiency Syndrome, the percentage of systemic mycoses in our country has increased.

Downloads

Download data is not yet available.

References

Rippon J. W. Medical Micology, Pathogenic Fungi and the Pathogenic Actinomycelej. 3ed.

Philadelphia: W.S. Sounders. 1974 Xt. 587p.

Kobayashi G.S y Pappagianis D. Preparation and standardization of antigens of H. capsulatum y

C . immitis Mycopath et Mycol Appl. 1970. 41: 139-153. https://doi.org/10.1007/BF02051490

Harrel W.K. et al. Procedural Manual for production of bacterial, fungal and parasitic reagents. Biological Reagents Section. Center for Disease Control. Atlanta. GA 1973.

Scott Laboratories. Inc Division of Microbiological Sciences. Inficke Ville. R102823 Carson CA

90746.

Mayorga R. Coccidioidomicosis en America Central. II Simposium de coccidioidomicosis.

Phoenix Arizona. 1965. 287-291 p.

Comunicación personal con la Dra. Conchita Toriello, jefe del Laboratorio de Micología, Depto. de

Ecología Humana. Facultad de Medicina, UNAM. Agosto 1988

Bodey G.P. y Fainstein V. Candidiasis Raven Press, New York, 1985. 271 p.

Published

1989-12-31

How to Cite

García de López, M. L., Logemann, H., & M. Vásquez, T. (1989). Production and standardization of fungal antigens and antiserums for the diagnosis of systematic mycoses. Revista Científica, 7(1), 16–17. https://doi.org/10.54495/Rev.Cientifica.v7i1.437

Issue

Section

Original Research Papers

Similar Articles

1 2 3 4 5 6 7 8 9 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)